8-KThe WireRed Alert
Executive Change · Bylaw Amendment
Filed Jun 18, 2024 · 2y ago · Accession 0001193125-24-163507
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K
- Filing date
- Jun 18, 2024
- Report date
- Jun 18, 2024
- Document
- d853800d8k.htm
- Size
- 263 KB